Stay updated on Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record is now available with detailed information about the completed Phase 1b cancer study, including treatment arms, eligibility criteria, locations, outcomes, and study documents.
    Difference
    100%
    Check dated 2026-11-08T19:42:20.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T19:26:07.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-25T22:02:17.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2, while the page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-18T22:42:25.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The site footer revision identifier was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T22:45:25.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The study record area displays a 403 Forbidden message and a Home link instead of study details.
    Difference
    0.5%
    Check dated 2026-10-04T22:23:51.000Z thumbnail image

Stay in the know with updates to Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page.